发明名称 Pyrimidyl cyclopentanes as Akt protein kinase inhibitors
摘要 The present invention provides compounds of Formula I, including tautomers, resolved enantiomers, diastereomers, solvates, metabolites, salts and pharmaceutically acceptable prodrugs thereof.; Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
申请公布号 US8846683(B2) 申请公布日期 2014.09.30
申请号 US201313753008 申请日期 2013.01.29
申请人 Array BioPharma, Inc.;Genentech, Inc. 发明人 Bencsik Josef R.;Blake James F.;Kallan Nicholas C.;Mitchell Ian S.;Spencer Keith L.;Xiao Dengming;Xu Rui;Chabot Christine;Liang Jun;Safina Brian S.
分类号 A61P35/00 主分类号 A61P35/00
代理机构 Viksnins Harris & Padys PLLP 代理人 Viksnins Harris & Padys PLLP
主权项 1. A method of treating a hyperproliferative disease or disorder in a mammal that is mediated by Akt signaling, said method comprising administering to said mammal an effective amount of a compound of Formula I:or an enantiomer or a pharmaceutically acceptable salt thereof, wherein: R1 and R1a are independently selected from H, Me, Et, vinyl, CF3, CHF2 or CH2F; R2 is H, OH, OMe or F; R2a is H, Me or F; R3 is H, Me, Et, or CF3; A is G is phenyl optionally substituted by one to four Re groups or a 5-6 membered heteroaryl optionally substituted by a halogen; R5 and R6 are independently H, OCH3, C3-C6-cycloalkyl optionally substituted with F, OH, C1-C3 alkyl or O(C1-C3 alkyl), 4-6 membered heterocycle optionally substituted with F, OH, C1-C3 alkyl, cyclopropylmethyl or C(=O)(C1-C3 alkyl), or C1-C6-alkyl optionally substituted with one or more groups independently selected from OH, oxo, O(C1-C6-alkyl), CN, F, NH2, NH(C1-C6-alkyl), N(C1-C6-alkyl)2, cyclopropyl, phenyl, imidazolyl, piperidinyl, pyrrolidinyl, morpholinyl, tetrahydrofuranyl, oxetanyl or tetrahydropyranyl, or R5 and R6 together with the nitrogen to which they are attached form a 4-7 membered heterocyclic ring optionally substituted with one or more groups independently selected from OH, halogen, oxo, CF3, CH2CF3, CH2CH2OH, O(C1-C3 alkyl), C(=O)CH3, NH2, NHMe, N(Me)2, S(O)2CH3, cyclopropylmethyl and C1-C3 alkyl, or Rc is hydrogen and Rd and R6 together with the atoms to which they are attached form a 4 to 6 membered heterocyclic ring having one nitrogen atom; Ra and Rb are H, or Ra is H, and Rb and R6 together with the atoms to which they are attached form a 5-6 membered heterocyclic ring having one or two ring nitrogen atoms; Rc and Rd are H or Me, or Rc and Rd together with the atom to which they are attached from a cyclopropyl ring; each Re is independently halogen, C1-C6-alkyl, C3-C6-cycloalkyl, O—(C1-C6-alkyl), CF3, OCF3, S(C1-C6-alkyl), CN, OCH2-phenyl, NH2, NO2, N—(C1-C6-alkyl)2, piperidine, pyrrolidine, CH2F, CHF2, OCH2F, OCHF2, OH, SO2(C1-C6-alkyl), C(O)NH2, C(O)NH(C1-C6-alkyl), and C(O)N(C1-C6-alkyl)2; m and n are independently 0, 1, 2 or 3 with the proviso that (m+n) must equal 2, 3 or 4; and p is 0 or 1.
地址 Boulder CO US